RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 41 filers reported holding RAIN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $7 | -86.5% | 6,000 | 0.0% | 0.00% | -87.5% |
Q1 2023 | $52 | +8.3% | 6,000 | 0.0% | 0.02% | +33.3% |
Q4 2022 | $48 | -99.8% | 6,000 | 0.0% | 0.02% | +63.6% |
Q3 2022 | $29,000 | -12.1% | 6,000 | 0.0% | 0.01% | -8.3% |
Q2 2022 | $33,000 | +10.0% | 6,000 | 0.0% | 0.01% | +20.0% |
Q1 2022 | $30,000 | -61.0% | 6,000 | 0.0% | 0.01% | -58.3% |
Q4 2021 | $77,000 | -14.4% | 6,000 | 0.0% | 0.02% | -25.0% |
Q3 2021 | $90,000 | -3.2% | 6,000 | 0.0% | 0.03% | -25.6% |
Q2 2021 | $93,000 | – | 6,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,571,379 | $7,967,000 | 2.01% |
Cormorant Asset Management, LP | 2,326,660 | $11,796,000 | 0.91% |
BVF INC/IL | 3,526,729 | $17,881,000 | 0.72% |
Boxer Capital, LLC | 1,175,000 | $5,957,000 | 0.31% |
Perceptive Advisors | 2,483,619 | $12,592,000 | 0.25% |
Logos Global Management LP | 134,194 | $680,000 | 0.09% |
Lumina Fund Management LLC | 6,000 | $30,000 | 0.01% |
Woodline Partners LP | 119,700 | $607,000 | 0.01% |
Trexquant Investment LP | 28,373 | $144,000 | 0.01% |
Alyeska Investment Group, L.P. | 125,000 | $634,000 | 0.01% |